These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30809097)

  • 1. Clinical outcome of
    Zhang Q; Gao HY; Li D; Li Z; Qi SS; Zheng S; Bai CS; Zhang SH
    Infect Drug Resist; 2019; 12():359-371. PubMed ID: 30809097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Retrospective Analysis of Risk Factors and Patient Outcomes of Bloodstream Infection with Extended-Spectrum β-Lactamase-Producing
    Xiao Y; Hang Y; Chen Y; Fang X; Cao X; Hu X; Luo H; Zhu H; Zhu W; Zhong Q; Hu L
    Infect Drug Resist; 2020; 13():4289-4296. PubMed ID: 33262623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Predictors and Mortality Between Bloodstream Infections Caused by ESBL-Producing Escherichia coli and ESBL-Producing Klebsiella pneumoniae.
    Scheuerman O; Schechner V; Carmeli Y; Gutiérrez-Gutiérrez B; Calbo E; Almirante B; Viale PL; Oliver A; Ruiz-Garbajosa P; Gasch O; Gozalo M; Pitout J; Akova M; Peña C; Molina J; Hernández-Torres A; Venditti M; Prim N; Origüen J; Bou G; Tacconelli E; Tumbarello M; Hamprecht A; Karaiskos I; de la Calle C; Pérez F; Schwaber MJ; Bermejo J; Lowman W; Hsueh PR; Navarro-San Francisco C; Bonomo RA; Paterson DL; Pascual A; Rodríguez-Baño J;
    Infect Control Hosp Epidemiol; 2018 Jun; 39(6):660-667. PubMed ID: 29618394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Factors for Extended-Spectrum-β-Lactamase-Producing
    Baek YJ; Kim YA; Kim D; Shin JH; Uh Y; Shin KS; Shin JH; Jeong SH; Lee GW; Lee EJ; Kim DS; Park YS
    Ann Lab Med; 2021 Sep; 41(5):455-462. PubMed ID: 33824233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and clinical outcomes of bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli in patients with cancer.
    Ha YE; Kang CI; Cha MK; Park SY; Wi YM; Chung DR; Peck KR; Lee NY; Song JH
    Int J Antimicrob Agents; 2013 Nov; 42(5):403-9. PubMed ID: 24071027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular analysis and risk factors for Escherichia coli producing extended-spectrum β-lactamase bloodstream infection in hematological malignancies.
    Cornejo-Juárez P; Pérez-Jiménez C; Silva-Sánchez J; Velázquez-Acosta C; González-Lara F; Reyna-Flores F; Sánchez-Pérez A; Volkow-Fernández P
    PLoS One; 2012; 7(4):e35780. PubMed ID: 22540004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for bloodstream infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: A focus on antimicrobials including cefepime.
    Chopra T; Marchaim D; Johnson PC; Chalana IK; Tamam Z; Mohammed M; Alkatib S; Tansek R; Chaudhry K; Zhao JJ; Pogue JM; Kaye KS
    Am J Infect Control; 2015 Jul; 43(7):719-23. PubMed ID: 25934068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence and Comparative Genomics Analysis of Extended-Spectrum-β-Lactamase-Producing Escherichia coli Carrying
    Feng C; Wen P; Xu H; Chi X; Li S; Yu X; Lin X; Wu S; Zheng B
    mSphere; 2019 Nov; 4(6):. PubMed ID: 31748247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic Burden of Patients with Bloodstream Infections Caused by Extended-Spectrum β-Lactamase-Producing
    Wang Y; Xiao T; Zhu Y; Ye J; Yang K; Luo Q; Shen P; Xiao Y
    Infect Drug Resist; 2020; 13():3583-3592. PubMed ID: 33116678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and Molecular Characterization of Extended Spectrum β-Lactamase and Carbapenemase-Producing
    Seman A; Mihret A; Sebre S; Awoke T; Yeshitela B; Yitayew B; Aseffa A; Asrat D; Abebe T
    Infect Drug Resist; 2022; 15():1367-1382. PubMed ID: 35378892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic.
    Kiratisin P; Apisarnthanarak A; Laesripa C; Saifon P
    Antimicrob Agents Chemother; 2008 Aug; 52(8):2818-24. PubMed ID: 18505851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality and molecular epidemiology associated with extended-spectrum β-lactamase production in Escherichia coli from bloodstream infection.
    Leistner R; Sakellariou C; Gürntke S; Kola A; Steinmetz I; Kohler C; Pfeifer Y; Eller C; Gastmeier P; Schwab F
    Infect Drug Resist; 2014; 7():57-62. PubMed ID: 24648746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of
    Abrar S; Ain NU; Liaqat H; Hussain S; Rasheed F; Riaz S
    Antimicrob Resist Infect Control; 2019; 8():80. PubMed ID: 31139363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors and outcomes in non-transplant patients with extended-spectrum beta-lactamase-producing
    Xiao T; Yang K; Zhou Y; Zhang S; Ji J; Ying C; Shen P; Xiao Y
    Antimicrob Resist Infect Control; 2019; 8():144. PubMed ID: 31467670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquisition of extended-spectrum beta-lactamase producing Escherichia coli strains in male and female infants admitted to a neonatal intensive care unit: molecular epidemiology and analysis of risk factors.
    Shakil S; Akram M; Ali SM; Khan AU
    J Med Microbiol; 2010 Aug; 59(Pt 8):948-954. PubMed ID: 20430903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective analysis of risk factors and outcomes in patients with extended-spectrum beta-lactamase-producing Escherichia coli bloodstream infections.
    Xiao T; Wu Z; Shi Q; Zhang X; Zhou Y; Yu X; Xiao Y
    J Glob Antimicrob Resist; 2019 Jun; 17():147-156. PubMed ID: 30634054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Cefotaxime-Resistant Escherichia coli Isolates from Healthy Cattle and Sheep in Northern Spain: Phenotypic and Genome-Based Characterization of Antimicrobial Susceptibility.
    Tello M; Ocejo M; Oporto B; Hurtado A
    Appl Environ Microbiol; 2020 Jul; 86(15):. PubMed ID: 32471914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for and mortality of extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli nosocomial bloodstream infections.
    Superti SV; Augusti G; Zavascki AP
    Rev Inst Med Trop Sao Paulo; 2009; 51(4):211-6. PubMed ID: 19739001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct use of eazyplex
    Fiori B; D'Inzeo T; Posteraro B; Menchinelli G; Liotti FM; De Angelis G; De Maio F; Fantoni M; Murri R; Scoppettuolo G; Ventura G; Tumbarello M; Pennestrì F; Taccari F; Sanguinetti M; Spanu T
    Infect Drug Resist; 2019; 12():1055-1062. PubMed ID: 31118711
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk factors associated with extended-spectrum β-lactamase-producing Enterobacteriaceae nosocomial bloodstream infections in a tertiary care hospital: a clinical and molecular analysis.
    Muro S; Garza-González E; Camacho-Ortiz A; González GM; Llaca-Díaz JM; Bosques F; Rositas F
    Chemotherapy; 2012; 58(3):217-24. PubMed ID: 22814216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.